These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 5406104

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E, D'Andrea F, Signorelli CD.
    Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
    [No Abstract] [Full Text] [Related]

  • 3. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F, Baroni A, Roveyaz L.
    Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
    [No Abstract] [Full Text] [Related]

  • 4. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
    Gerstenbrand F, Grünberger J, Schubert H.
    Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895
    [No Abstract] [Full Text] [Related]

  • 5. [Therapy of parkinsonian syndromes with L-dopa. Results and prospects].
    Fazio C.
    Sist Nerv; 1970 Aug; 22(2):61-6. PubMed ID: 5504558
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment with L-dopa in Parkinsonian syndromes].
    De Renzi E, Pieczuro A.
    Sist Nerv; 1970 Aug; 22(1):1-11. PubMed ID: 5502951
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The Rorschach test in parkinsonian patients. Its course during treatment with L dopa. Its prognostic value].
    Sevilla M, Vernet JP, Becle J, Darcourt G.
    Ann Med Psychol (Paris); 1973 May; 1(5):577-608. PubMed ID: 4761931
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
    Rosati G, Agnetti V, Mura F, Granieri E.
    Minerva Med; 1974 May 02; 65(33):1811-23. PubMed ID: 4602058
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of parkinsonism with the drug L-DOPA].
    Stoliarova LG, Kistenev BA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 May 02; 73(2):199-205. PubMed ID: 4795170
    [No Abstract] [Full Text] [Related]

  • 12. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J, Raymondeaud C, Piot C.
    Rev Neurol (Paris); 1970 Feb 02; 122(2):145-8. PubMed ID: 4931718
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Habituation of trigemino-facial reflexes in parkinsonism treated with L-DOPA].
    Messina C.
    Riv Neurol; 1970 Feb 02; 40(5):327-36. PubMed ID: 5507461
    [No Abstract] [Full Text] [Related]

  • 18. [Study of L-dopa treatment and its principal side effects in aged subjects].
    Antonini F, Baroni A, Bucalossi A, Roveyaz L.
    Gerontol Clin (Basel); 1972 Feb 02; 14(5):297-309. PubMed ID: 4144357
    [No Abstract] [Full Text] [Related]

  • 19. Cerebrospinal fluid N-acetyl neuraminic acid in Parkinson's disease, before and after L-dopa therapy.
    Lipman IJ, Papadopoulos NM.
    Dis Nerv Syst; 1973 Jan 02; 34(1):59-62. PubMed ID: 4709194
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of the Parkinson syndrome with amantadine].
    Hartmann-von Monakow K.
    Schweiz Med Wochenschr; 1971 Dec 04; 101(48):1736-9. PubMed ID: 5140093
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.